KALY Announces Anchor Investor In Cannabis Biopharmaceutical Technology At $50 Million Valuation
Dallas, TX – December 17, 2019 — OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) (“KALY”) today announced an anchor investor in its biopharmaceutical technology. KALY recently announced restructuring its cannabis biopharmaceutical business as part of a strategy to facilitate a strategic investment at a $50 million valuation. KALY
KALY – Kali-Extracts Expects 2020 Revenue Growth Acceleration From CBD Infused Consumer Products
Dallas, TX – December 11, 2019 — OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) (“KALY”) today announced expected revenue growth acceleration in 2020 from the sales of CBD infused consumer products. The company currently generates revenue from the sale of CBD infused candies and beverages. KALY produces and
KALY – Kali-Extracts Announces Cannabis Biopharmaceutical Business Restructuring
Dallas, TX – December 10, 2019 — OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) (“KALY”) today announced the company is restructuring its cannabis biopharmaceutical business. KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions (see below). KALY has recently announced receiving
KALY – Kali-Extracts Proceeds With Capital Infusion Plan At $50 Million Valuation
Dallas, TX – December 6, 2019 — OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) (“KALY”) today announced it will proceed with a capital infusion plan to accelerate the growth of its cannabis biopharmaceutical technology. KALY has recently announced receiving two inquiries into the acquisition of the company’s cannabis
PURA and KALY Announce Landing First Kenyan Coffee Shipment Adding To $8 Million 2020 Beverage Revenue Target
Dallas, TX – December 3, 2019 — OTC PR WIRE – Puration, Inc. (OTC: PURA) today announced the company has landed its first Kenyan coffee shipment. The company recently announced it will begin producing CBD infused Fair Trade coffee from Kenya. Now that the first shipment from Kenya has arrived, the company can
KALY – Kali-Extracts Anticipates Reaching $1 Million In 2019 Revenue With Q4 Hemp Extraction Contribution
Dallas, TX – November 29, 2019 — OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced that it anticipates reaching $1 million in revenue by year end 2019 with the contribution of its first hemp extraction contracts being realized in the fourth quarter of 2019.
KALY – Kali-Extracts Could Reach $1 Million In Total 2019 Revenue
Dallas, TX – November 27, 2019 — OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed that it has the potential to reach $1 million in revenue by year end 2019. The company yesterday published a financial performance update in conjunction with KALY’s financial performance report through
KALY – Kali-Extracts Financial Performance Update Tomorrow November 26, 2019
Dallas, TX – November 25, 2019 —OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a management financial performance update scheduled for release tomorrow, November 26, 2019. The update will be published in conjunction with KALY’s financial performance report through September 30, 2019. Management will highlight the company’s
KALY – Kali-Extracts Confirms Cannabis Biopharmaceutical Capital Infusion Plans
Dallas, TX – November 21, 2019 – OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed introducing a third option to compete with the two acquisition offers currently being entertained by KALY management. KALY has recently announced receiving two inquiries into the acquisition of the company’s cannabis biopharmaceutical
KALY – Kali-Extracts Introduces Third Option To Compete With Two $50 Million Acquisition Offers
Dallas, TX – November 20, 2019 — OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced introducing a third option to compete with the two acquisition offers currently being entertained by KALY management. KALY has recently announced receiving two inquiries into the acquisition of the company’s cannabis biopharmaceutical
Contact Us
- 707-OTC-WIRE (707-682-9473)
- cs@otcprwire.com
Recent Comments